This inventor holds 1 USPTO granted patent. Top assignee: Pliva, Farmaceutska, Kemijska, Prehrambena I Kozmeticka Industrija,. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Miljenko Dumi C: Innovator in Hypoglycemic Research
Introduction
Miljenko Dumi C is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with hypoglycemic activity. His work is characterized by a focus on innovative chemical solutions that address important health issues.
Latest Patents
Dumi C holds a patent for "Hydroxylamines with hypoglycemic activity." This patent describes the preparation of novel 1-(2-,3- or 4-hydroxylaminobenzensulfonyl-1a,2,6,6 a-tetrahydro-1H,4H-[1,3]-dioxepino[5,6-b]azirines with hypoglycemic activity through the selective reduction of appropriate 1-(2-,3- or 4-nitrobenzenesulfonyl) derivatives. This innovative approach has the potential to contribute to diabetes management.
Career Highlights
Miljenko Dumi C is associated with Pliva, a prominent pharmaceutical, chemical, food, and cosmetic industry company. His work at Pliva has allowed him to engage in cutting-edge research and development, furthering advancements in medical science.
Collaborations
Dumi C has collaborated with several talented individuals, including Mirela E Skinja and Blanka Jamnicky. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Miljenko Dumi C is a distinguished inventor whose work in hypoglycemic research exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to pave the way for advancements in health solutions.